About Sequentia biotech
Sequentia biotech is a company based in Barcelona (Spain) founded in 2013.. Sequentia biotech has raised $11.16 million across 9 funding rounds from investors including European Union, Seventure Partners and EIC Fund. Sequentia biotech offers products and services including Cloud Software, Custom Software, and Consulting Services. Sequentia biotech operates in a competitive market with competitors including Human Longevity, Omniome, Genomics, Depixus and Seven Bridges Genomics, among others.
- Headquarter Barcelona, Spain
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sequentia Biotech Sl
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.16 M (USD)
in 9 rounds
-
Latest Funding Round
$11.16 M (USD), Series A
Sep 30, 2024
-
Investors
European Union
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sequentia biotech
Sequentia biotech offers a comprehensive portfolio of products and services, including Cloud Software, Custom Software, and Consulting Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
User-friendly tools for daily omics data analysis tasks
Pipelines for processing large volumes of omics data
Expert guidance on transforming omics data into knowledge
Unlock access to complete
Funding Insights of Sequentia biotech
Sequentia biotech has successfully raised a total of $11.16M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $11.16 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series A — $11.2M
-
First Round
First Round
(03 Jan 2017)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series A - Sequentia biotech | Valuation | Seventure Partners | |
| Sep, 2022 | Amount | Grant - Sequentia biotech | Valuation |
investors |
|
| Jun, 2021 | Amount | Grant - Sequentia biotech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sequentia biotech
Sequentia biotech has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Seventure Partners and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sequentia biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sequentia biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sequentia Biotech Comparisons
Competitors of Sequentia biotech
Sequentia biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Human Longevity, Omniome, Genomics, Depixus and Seven Bridges Genomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomics data and cell therapy-based diagnostic and therapeutic solutions
|
|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
Genomic risk assessment and prevention platform is provided.
|
|
| domain | founded_year | HQ Location |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sequentia Biotech
Frequently Asked Questions about Sequentia biotech
When was Sequentia biotech founded?
Sequentia biotech was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Where is Sequentia biotech located?
Sequentia biotech is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Is Sequentia biotech a funded company?
Sequentia biotech is a funded company, having raised a total of $11.16M across 9 funding rounds to date. The company's 1st funding round was a Grant of $61.32K, raised on Jan 03, 2017.
What does Sequentia biotech do?
Sequentia Biotech was founded in 2013 and is based in Barcelona, Spain. Operations in the bioinformatics sector are structured across four divisions: Sequentia Green, Sequentia Health, Sequentia Research, and Sequentia Training. Bioinformatics services, next-generation sequencing (NGS), and data analysis software are offered. Custom databases, including PRGdb for plant resistance genes and Variation DB, are also maintained to support specialized research needs.
Who are the top competitors of Sequentia biotech?
Sequentia biotech's top competitors include Human Longevity, Novogene Corporation and Eagle Genomics.
What products or services does Sequentia biotech offer?
Sequentia biotech offers Cloud Software, Custom Software, and Consulting Services.
Who are Sequentia biotech's investors?
Sequentia biotech has 3 investors. Key investors include European Union, Seventure Partners, and EIC Fund.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.